Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02447497 · ClinicalTrials.gov registry record · Phase 2
In Vivo Patient Preoperative Skin Prep Persistence
A Phase 2 study, sponsored by Solventum US.
- Completed
- Registry status
- Phase 2
- Development phase
- 27
- Enrollment target
NCT02447497 is a Phase 2 study that has completed, run by Solventum US. The registered enrollment target is 27 participants.
The verdict
NCT02447497, a Phase 2 study, has completed, sponsored by Solventum US.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 27 participants
- Enrollment target
Study Summary
The objective of the study is to demonstrate persistence of the CHG/IPA Prep on skin flora of the abdominal and inguinal regions of human subjects.
Interventions
- DRUG 3M CHG/IPA Surgical Skin Preparation - Abdominal Region
- OTHER Normal Saline - Abdominal Region
- DRUG 3M CHG/IPA Surgical Skin Preparation - Inguinal Region
- OTHER Normal Saline - Inguinal Region
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2015-03 |
| Est. Completion | 2015-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02447497
The ClinicalTrials.gov registry entry for NCT02447497 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Solventum US, which has 41 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which 3M CHG/IPA Surgical Skin Preparation - Abdominal Region is the first listed.
NCT02447497 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02447497 about?
NCT02447497 is a clinical study titled "In Vivo Patient Preoperative Skin Prep Persistence". The objective of the study is to demonstrate persistence of the CHG/IPA Prep on skin flora of the abdominal and inguinal regions of human subjects.
What is the current status of trial NCT02447497?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 27 participants. The study started on 2015-03. Estimated completion is 2015-04.
What interventions are being tested in trial NCT02447497?
The interventions under investigation include: 3M CHG/IPA Surgical Skin Preparation - Abdominal Region (DRUG), Normal Saline - Abdominal Region (OTHER), 3M CHG/IPA Surgical Skin Preparation - Inguinal Region (DRUG), Normal Saline - Inguinal Region (OTHER).
Who is sponsoring clinical trial NCT02447497?
This trial is sponsored by Solventum US, which has 41 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.